<?xml version="1.0" encoding="UTF-8"?>
<p>Tocilizumab (Tmab) is a humanized monoclonal antibody that has been approved for the therapy of patients with rheumatoid arthritis. It inhibits IL-6, which is secreted by monocytes and macrophages, and which is significantly increased in patients who have developed the “cytokine storm” described above.(
 <xref rid="R12" ref-type="bibr">12</xref>)
</p>
